Literature DB >> 15048993

Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry.

Katie L Meehan1, Marianne D Sadar.   

Abstract

Androgens are involved in the pathogenesis of diseases including adenocarcinoma of the prostate. These hormones are important for growth, maintenance, and integrity of structure and function of the prostate. Androgen-deprivation is currently the only effective systemic therapy for prostate cancer but the effects of androgens on the proteome are still poorly described. Here we quantitatively profile changes in the proteome of LNCaP human prostate cancer cells in response to androgen using the newly developed isotope-coded affinity tag (ICAT) labeling and two-dimensional liquid chromatography-tandem mass spectroscopy (2-D LC-MS/MS). ICAT enables the concurrent identification and comparative quantitative analysis of proteins present in various biological samples including human cell and tissue extracts. Quantification and identification of 139 proteins in complex protein mixtures obtained from androgen-stimulated and unstimulated LNCaP cells were achieved. Changes in levels of 77 proteins in response to androgens were detected. Some of these proteins have been previously reported to be regulated by androgens and include spermine synthase, fatty acid synthase and calreticulin precursor. A large number of proteins that have not been previously reported to be expressed in prostate cells were also quantitatively identified. Examples of these include members of the dual specificity protein phosphatase subfamily, "similar" to hypothetical protein DKFZp434B0328.1, "similar" to 14-3-3 protein zeta and "similar" to hypothetical protein 458, components of the actin cytoskeleton and a range of unknown/uncharacterized proteins. This catalogue of proteins provides an overview of the proteome of prostate cancer cells and the global changes that occur in response to androgens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048993     DOI: 10.1002/pmic.200300649

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  11 in total

1.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

2.  Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.

Authors:  Harryl D Martinez; Jordy J Hsiao; Rohini J Jasavala; Izumi V Hinkson; Jimmy K Eng; Michael E Wright
Journal:  Genes Cancer       Date:  2011-10

3.  14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.

Authors:  Mark A Titus; Jiann-An Tan; Christopher W Gregory; O Harris Ford; Romesh R Subramanian; Haian Fu; Elizabeth M Wilson; James L Mohler; Frank S French
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

4.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

Review 5.  Cancer proteomics by quantitative shotgun proteomics.

Authors:  Emily I Chen; John R Yates
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

6.  Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Ranju Ralhan; Leroi V Desouza; Ajay Matta; Satyendra Chandra Tripathi; Shaun Ghanny; Siddartha Datta Gupta; Sudhir Bahadur; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2008-03-13       Impact factor: 5.911

7.  Differential proteomics in the aging Noble rat ventral prostate.

Authors:  Ying Wai Lam; Neville N C Tam; James E Evans; Karin M Green; Xiang Zhang; Shuk-Mei Ho
Journal:  Proteomics       Date:  2008-07       Impact factor: 3.984

8.  Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.

Authors:  Nagireddy Putluri; Ali Shojaie; Vihas T Vasu; Srilatha Nalluri; Shaiju K Vareed; Vasanta Putluri; Anuradha Vivekanandan-Giri; Jeman Byun; Subramaniam Pennathur; Theodore R Sana; Steven M Fischer; Ganesh S Palapattu; Chad J Creighton; George Michailidis; Arun Sreekumar
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

9.  Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.

Authors:  Greg N Brooke; Simon C Gamble; Michael A Hough; Shajna Begum; D Alwyn Dart; Michael Odontiadis; Sue M Powell; Flavia M Fioretti; Rosie A Bryan; Jonathan Waxman; Robin Wait; Charlotte L Bevan
Journal:  Mol Cell Proteomics       Date:  2015-02-18       Impact factor: 5.911

10.  Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases.

Authors:  Adaikkalam Vellaichamy; Arun Sreekumar; John R Strahler; Theckelnaycke Rajendiran; Jindan Yu; Sooryanarayana Varambally; Yong Li; Gilbert S Omenn; Arul M Chinnaiyan; Alexey I Nesvizhskii
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.